The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS).
 
Maria Catherine Pietanza
Honoraria - Celgene; Genentech
Consulting or Advisory Role - Celgene; Genentech
Speakers' Bureau - PER; Quintiles
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); OncoMed (Inst); Stem CentRx (Inst)
 
Helen H. Won
No Relationships to Disclose
 
Natasha Rekhtman
No Relationships to Disclose
 
Lu Wang
No Relationships to Disclose
 
William D. Travis
No Relationships to Disclose
 
Lee M. Krug
Consulting or Advisory Role - Morphotek
Speakers' Bureau - Clovis Oncology; Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); MedImmune (Inst)
 
Anna M. Varghese
No Relationships to Disclose
 
Paul K. Paik
Honoraria - Celgene
Consulting or Advisory Role - Celgene; Threshold Pharmaceuticals
Research Funding - AstraZeneca; GlaxoSmithKline
 
Gregory J. Riely
Honoraria - Celgene
Consulting or Advisory Role - ARIAD; Mersana; Novartis; Roche
Research Funding - GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis
 
Maureen Frances Zakowski
No Relationships to Disclose
 
Marc Ladanyi
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Exelixis; Genentech/Roche; Novartis; Pfizer; Threshold Pharmaceuticals
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AVEO; Boehringer Ingelheim; GlaxoSmithKline; Merck
Research Funding - Biomarin